Voglitor R 0.5/0.2 Tablet

Introduction

Voglitor R is a medication that combines two active ingredients: Repaglinide and Voglibose. Repaglinide belongs to a class of drugs called meglitinides, while Voglibose is classified as an alpha-glucosidase inhibitor. This combination medication is commonly prescribed to manage blood sugar levels in people with type 2 diabetes.

Uses

Voglitor R is primarily used to control blood sugar levels in individuals with type 2 diabetes. It is prescribed alongside a healthy diet and regular exercise to help regulate glucose levels in the body. By stimulating the release of insulin from the pancreas and reducing the absorption of glucose from the intestines, Voglitor R helps to lower blood sugar levels after meals.

Dosage and Administration

The dosage of Voglitor R may vary depending on individual needs and medical condition. Follow the instructions provided by your healthcare professional. Generally, the recommended starting dose is one tablet taken orally before each main meal. The maximum daily dose should not exceed 16 mg of Repaglinide and 4 mg of Voglibose.

Mechanism of Action

Repaglinide works by stimulating the beta cells in the pancreas to release insulin, a hormone that helps regulate blood sugar levels. It achieves this by binding to specific receptors on the beta cells, promoting the release of insulin in response to elevated blood glucose levels. Voglibose, on the other hand, inhibits the action of certain enzymes in the intestines, slowing down the digestion and absorption of carbohydrates. This mechanism helps to reduce the rise in blood glucose levels after meals.

Side Effects

Common side effects may include:

• Hypoglycemia (low blood sugar)
• Nausea or vomiting
• Diarrhea or constipation
• Abdominal pain
• Headache

If any of these side effects persist or worsen, consult your healthcare professional. Additionally, Voglitor R may also cause more serious side effects, such as severe allergic reactions or liver problems. Seek immediate medical attention if you experience any signs of an allergic reaction, such as rash, itching, swelling, dizziness, or trouble breathing.

Drug Interactions

Voglitor R may interact with other medications, including:

• Beta-blockers
• Monoamine oxidase inhibitors (MAOIs)
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Anticoagulants

inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs, supplements, and herbal products, to avoid potential drug interactions. They can provide guidance on the safety and appropriate use of Voglitor R in combination with other medications.

Precautions

Before starting Voglitor R, inform your healthcare professional about any existing medical conditions, including liver or kidney problems. This medication may not be suitable for everyone and should be used with caution in certain situations. It is contraindicated in individuals with a history of hypersensitivity to Repaglinide, Voglibose, or any other components of the medication. Voglitor R should also be used with caution in individuals with inflammatory bowel disease or intestinal obstruction.

Storage

Voglitor R should be stored at room temperature, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use Voglitor R if it has passed its expiration date, and always check the packaging for any signs of damage before use.

Patient Tips

Here are a few tips to help you get the most out of your treatment with Voglitor R:

• Take your medication exactly as prescribed by your healthcare professional.
• follow a healthy diet and maintain a regular exercise routine while taking Voglitor R.
• Monitor your blood sugar levels regularly and report any significant changes to your healthcare professional.
• Carry a source of fast-acting sugar, such as glucose tablets or candy, in case you experience symptoms of low blood sugar.
• Attend regular check-ups with your healthcare professional to monitor your progress and discuss any concerns or questions you may have.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Prandin 0.5mg tablets (Health Professionals SmPC) Available at:
• Repaglinide (Drugs.com) [Accessed 8 Jun. 2024] (online) Available at:
• repaglinide (RX) [Accessed 1 Jun. 2024] (online) Available at:
• Repaglinide (MedlinePlus) [Accessed 29 Jun. 2024] (online) Available at:
• Balfour JA, Faulds D. Repaglinide. Drugs Aging. 1998 Aug;13(2):173-80. doi: 10.2165/00002512-199813020-00008. [Accessed 30 Jun. 2024] Available at: